Health Care/Hospital News & Press Release Distribution

Hyundai Motor's Mini '45' EV Puts Emotions in Motion

SEOUL, South Korea, Dec. 15, 2020 /PRNewswire/ -- Hyundai Motor Company unveiled details of its one-of-a-kind mini EV based on the '45' concept car in a short film on YouTube. The 6-minute video shows how the minicar uses Emotion Adaptive Vehicle Control (EAVC) technology to support young patient...

2020-12-15 07:30 16685

Hyundai Motor's Mini '45' EV Puts Emotions in Motion

Otto Damsma Joins Bioforum as Vice President of Asia Pacific Operations

Bioforum Bolsters Leadership Team to Drive Expansion in Australia and Asia Pacific Region NESS ZIONA, Israel, Dec. 15, 2020 /PRNewswire/ -- Bioforum , a global data-focused contract research organization (CRO), today announced the appointment ofOtto Damsma as Vice Pr...

2020-12-15 05:00 1638

Regent Pacific Completes Acquisition of Deep Longevity, Inc

* Expands into the emerging field of artificial intelligence (AI) and longevity medicine * Strengthens shareholder mix by adding experienced longevity and wellness biotechnology investors and entrepreneurs HONG KONG, Dec. 15, 2020 /PRNewswire/ --Regent Pacific Group Limited ("Regent Pacific" ...

2020-12-15 02:03 13740

Mercy Ships Announces Retirement Of Board Chairman Myron Ullman, Who Has Been Instrumental In Achieving Its Mission Of Bringing Hope And Healing To The World's Most Disadvantaged Peoples

Since he became Chairman in 2001, Mercy Ships has seen exceptional growth including reaching the milestone of performing more than 100,000 surgical procedures on board its charity hospital ships, attracting 20,000 volunteers from 60 nations, and providing healthcare services and materials worth m...

2020-12-14 23:00 1280

Ruben S. Martin III Elected Chairman Of Mercy Ships International's Board Of Directors

Highly Accomplished Business Leader and Philanthropist has been a Long-Time Board Member and Supporter of Mercy Ships and its Work to Bring Hope and Healing to the World's Most Disadvantaged Peoples GARDEN VALLEY, Texas, Dec. 14, 2020 /PRNewswire/ -- Mercy Ships, the global healthcare charity th...

2020-12-14 23:00 3264

CipherHealth Recognized with Enabling Technology Leadership Award by Frost & Sullivan for its Patient Engagement Platform

The CipherHealth platform supports patient engagement through the entire continuum of care to deliver superior operational efficiency, improved outcomes and bottom-line growth SANTA CLARA, Calif., Dec. 14, 2020 /PRNewswire/ -- Based on its recent analysis of the North American patient engagement...

2020-12-14 23:00 1611

CipherHealth Recognized with Enabling Technology Leadership Award by Frost & Sullivan for its Patient Engagement Platform

Mercy Ships Announces Retirement Of Board Chairman Myron Ullman, Who Has Been Instrumental In Achieving Its Mission Of Bringing Hope And Healing To The World's Most Disadvantaged Peoples

Since he became Chairman in 2001, Mercy Ships has seen exceptional growth including reaching the milestone of performing more than 100,000 surgical procedures on board its charity hospital ships, attracting 20,000 volunteers from 60 nations, and providing healthcare services and materials worth m...

2020-12-14 23:00 1341

Ruben S. Martin III Elected Chairman Of Mercy Ships International's Board Of Directors

Highly Accomplished Business Leader and Philanthropist has been a Long-Time Board Member and Supporter of Mercy Ships and its Work to Bring Hope and Healing to the World's Most Disadvantaged Peoples GARDEN VALLEY, Texas, Dec. 14, 2020 /PRNewswire/ -- Mercy Ships, the global healthcare charity th...

2020-12-14 23:00 3349

Sunshine Guojian Selects Verseau's VSIG4-targeted Antibody as the Second Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- 3SBio Inc. ("3SBio")'s subsidiary, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. ("Sunshine Guojian") and Verseau Therapeutics, Inc. ("Verseau") today announced the selection of a monoclonal antibody targeting VSIG4, as a ...

2020-12-14 22:28 1571

I-Mab Added to Nasdaq Biotechnology Index

SHANGHAI and GAITHERSBURG, Md., Dec. 14, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab's American Depositary Shares (ADS) have been ...

2020-12-14 21:00 8454

Regent Pacific's Commercial Strategic Partner Receives Approval from Taiwan Food and Drug Administration

HONG KONG, Dec. 14, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Orient EuroPharma Co., L...

2020-12-14 20:20 3741

Canadian pilot study suggests prescription icosapent ethyl (VASCEPA®) might improve symptoms of COVID-19 and reduce inflammation

TORONTO, ON, Dec. 14, 2020 /PRNewswire/ -- The results of a Canadian study released this weekend provides encouraging data suggesting that the prescription strength omega-3 called icosapent ethyl (VASCEPA) may reduce inflammation and improve symptoms in patients with a diagnosis of COVID-19. "Th...

2020-12-14 20:00 1790

Sai Life Sciences releases its first Sustainability Report

- Developed as per the Global Reporting Initiative (GRI) standards - Highlights the various sustainable choices embraced by the company in steering its journey on a sustainable path HYDERABAD, India, Dec. 14, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Resear...

2020-12-14 18:42 1894

Sai Life Sciences releases its first Sustainability Report

Hummingbird Bioscience Announces Collaboration with Tempus to Harness AI-driven Precision Medicine to Accelerate Clinical Development of HMBD-001 In HER3 Driven Cancers

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing revolutionary therapies for hard-to-drug targets, today announced a collaboration with Tempus, a leader in artificial intelligence and precision medicine, to drive t...

2020-12-14 18:00 1522

Ortoma launches OTS 5 according to plan

STOCKHOLM, Dec. 14, 2020 /PRNewswire/ -- Ortoma, manufacturer of surgical assistive technology for planning and positioning of implants, launches the latest version of the company's surgical system Ortoma Treatment Solution (OTS), which is based on AI (Artificial Intelligence). Ongoing active mar...

2020-12-14 16:28 1147

Exploring Breast Cancer from a 3-Dimensional Perspective

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- Every October, the streets (and Internet) are rife with various awareness campaigns and pink ribbon projects that boost information on breast cancer and available screening methods. Despite an abundance of information available through mass-distributed br...

2020-12-14 15:31 1332

China Life Singapore-special supported 'Love & Hope' Gala Concert to be dedicated to outstanding frontline workers

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- On December 13, 2020, the "Love & Hope" Gala Concert, organized by Huaxia Cultural Hub, was held in the Singapore Conference Hall, presenting a wonderful musical performance for locals. China Life Insurance (Singapore) Pte. Ltd. ("China Life Singapore")pro...

2020-12-14 14:44 2612

China Life Singapore-special supported 'Love & Hope' Gala Concert to be dedicated to outstanding frontline workers

TCEB Leveraging MICE Personnel to Support Government's Special Arrangement for the Entry of Overseas Investors

BANGKOK, Dec. 14, 2020 /PRNewswire/ -- Thailand Convention and Exhibition Bureau (TCEB), in collaboration with Department of Disease Control, has launched the specialised training for Destination Management Company (DMC) to design health-compliant itineraries as part of a government's special ar...

2020-12-14 14:29 1703

TCEB Leveraging MICE Personnel to Support Government's Special Arrangement for the Entry of Overseas Investors

Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances

PALO ALTO, Calif., Dec. 14, 2020 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of a human proof-of-concept study for Alzheimer's Disease using its proprietary cell-free messenger RNA (cf-mRNA)-Artificial Intelligence Technology Plat...

2020-12-14 13:00 1212

Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Viva Biotech's Online Investor Day was successfully hosted onDecember 8, 2020. The management team conducted an online dialogue with nearly 400 investors, focusing on the company's strategy, personnel plans, technology platforms, integration strategic plans...

2020-12-14 12:15 2197